Atrial Fibrillation Trial, Recruiting (NCT07563257)

Atrial Fibrillation Trial, Recruiting NCT07563257 Sponsor: Maxime Zabern Condition: Atrial Fibrillation

Printed from Voxsanity (voxsanity.com.au) — NCT07563257 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Atrial Fibrillation

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are 18 years of age or older.
People who have been diagnosed with a type of irregular heart rhythm called persistent atrial fibrillation and/or atrial flutter.
People who are already scheduled to have a heart procedure called catheter ablation (either for the first time or as a repeat procedure), where the plan includes making specific line-shaped treatment areas in the heart.
People who are able to sign a written consent form agreeing to take part.

Who may not be able to join:

People whose irregular heart rhythm comes and goes (paroxysmal) or is persistent, if the planned procedure only involves a standard treatment targeting a specific area of the heart called the pulmonary veins.
People who have an artificial (mechanical) mitral heart valve.
People who have a blood clot inside the heart, or who cannot safely take blood-thinning medication.
People who have a medical condition or physical characteristic that the trial doctor believes would make participation unsafe (confirm with trial site).
People who are pregnant.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Maxime Zabern, MD, Assaf-Harofeh Medical Center

Phone: +972-54-5644963

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07563257

Sponsor: Maxime Zabern

Phase: Not Applicable

Status: Recruiting

Condition: Atrial Fibrillation

Trial contact: +972-54-5644963

More information: https://clinicaltrials.gov/study/NCT07563257

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are 18 years of age or older.
People who have been diagnosed with a type of irregular heart rhythm called persistent atrial fibrillation and/or atrial flutter.
People who are already scheduled to have a heart procedure called catheter ablation (either for the first time or as a repeat procedure), where the plan includes making specific line-shaped treatment areas in the heart.
People who are able to sign a written consent form agreeing to take part.

Who may not be able to join:

People whose irregular heart rhythm comes and goes (paroxysmal) or is persistent, if the planned procedure only involves a standard treatment targeting a specific area of the heart called the pulmonary veins.
People who have an artificial (mechanical) mitral heart valve.
People who have a blood clot inside the heart, or who cannot safely take blood-thinning medication.
People who have a medical condition or physical characteristic that the trial doctor believes would make participation unsafe (confirm with trial site).
People who are pregnant.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Maxime Zabern

Registry

ClinicalTrials.gov

Start date

12 May 2026

Est. completion

1 May 2027

Where this trial is recruiting

🇮🇱 Israel

Primary endpoints

Concordance; Workflow Efficiency

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov